Close Menu

Michael J. Fox Foundation

Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.

The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.

The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.

The study will provide researchers, drugmakers, regulators, and payors with insight into the genetics of the disease and experience of the patients.

Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.

The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method. 

NEW YORK (GenomeWeb) – The Michael J. Fox Foundation for Parkinson's Research has awarded Sok Kean Khoo, an associate professor of molecular genomics at Grand Valley State University, a $110,000 grant to study molecular biomarkers for monitoring the advancement of Parkinson's disease.

NEW YORK (GenomeWeb News) – KineMed today reported the Michael J. Fox Foundation has awarded it an additional $1.2 million to continue development of kinetic biomarkers for Parkinson's disease.

NEW YORK (GenomeWeb News) – Lucigen today announced it has received a $187,000 grant from the Michael J. Fox Foundation to study a protein that has been implicated in Parkinson's disease.

A 23andMe and Parkinson's Institute team has tracked down two new risk loci for Parkinson's disease and verified many more through a web-based genome-wide association study involving more than 3,400 cases and nearly 30,000 controls.

Pages

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.